ABT Stock Ownership Activity

ABBOTT LABORATORIES 13F holders

2 value investing gurus have made changes to the ABBOTT LABORATORIES (ABT) position according to the gurus' latest SEC quarterly report(s). The number of ABT shares has been increased by 1, decreased by 1 super investor(s).

Which gurus or hedge funds are buying ABT now?

According to the latest SEC filing(s) ABBOTT LABORATORIES (ABT) has been bought by David M. Polen - Polen Capital Management (added shares +0.05%).

To see more about who is investing in ABBOTT LABORATORIES (ABT), please go to the ABT ownership page.

2014 Q1 (4 results)
David M. Polen
-0.73%
-55,603
-0.05%
6.32%
Eric H. Schoenstein
+0.57%
+18,715
+0.01%
1.83%
Robert Olstein
+1.68%
+3,000
+0.02%
0.96%
Daniel Loeb
-100.00%
-3,250,000
-1.96%
0.00%
Current price: $107.53 179.22% AVG reported price*: $38.51
2013 Q4 (4 results)
David M. Polen
+22.39%
+1,398,291
+1.19%
6.48%
Eric H. Schoenstein
-41.90%
-1,847,299
-1.29%
1.39%
Robert Olstein
+23.45%
+31,110
+0.19%
0.90%
Daniel Loeb
buy
+3,250,000
+2.36%
0.00%
Current price: $107.53 180.54% AVG reported price*: $38.33
2013 Q3 (4 results)
David M. Polen
-5.54%
-366,097
-0.28%
4.77%
Eric H. Schoenstein
+1.27%
+70,999
+0.04%
2.90%
Robert Olstein
+12.40%
+8,480
+0.08%
0.39%
Thomas Russo
+0.23%
+200
+0.00%
0.03%
Current price: $107.53 223.98% AVG reported price*: $33.19
2013 Q2 (4 results)
Eric H. Schoenstein
buy
+5,581,244
+3.19%
3.19%
David M. Polen
buy
+3,371,224
+5.48%
2.80%
Robert Olstein
buy
+81,270
+0.72%
0.45%
Thomas Russo
buy
+54,802
+0.04%
0.02%
Current price: $107.53 208.28% AVG reported price*: $34.88
16 of 115

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.